Literature DB >> 15634953

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media.

D Bogaert1, R H Veenhoven, M Sluijter, W J W Wannet, G T Rijkers, T J Mitchell, S C Clarke, W H F Goessens, A G Schilder, E A M Sanders, R de Groot, P W M Hermans.   

Abstract

A randomized double-blind trial with a 7-valent pneumococcal conjugate vaccine was conducted in The Netherlands among 383 children, aged 1 to 7 years, with a history of recurrent acute otitis media. No effect of vaccination on the pneumococcal colonization rate was found. However, a shift in serotype distribution was clearly observed (R. Veenhoven et al., Lancet 361:2189-2195, 2003). We investigated the molecular epidemiology of 921 pneumococcal isolates retrieved from both the pneumococcal vaccine (PV) and control vaccine (CV) groups during the vaccination study. Within individuals a high turnover rate of pneumococcal restriction fragment end labeling genotypes, which was unaffected by vaccination, was observed. Comparison of the genetic structures before and after completion of the vaccination scheme revealed that, despite a shift in serotypes, there was clustering of 70% of the pneumococcal populations. The remaining isolates (30%) were equally observed in the PV and CV groups. In addition, the degree of genetic clustering was unaffected by vaccination. However, within the population genetic structure, nonvaccine serotype clusters with the serotypes 11, 15, and 23B became predominant over vaccine-type clusters after vaccination. Finally, overall pneumococcal resistance was low (14%), and, albeit not significant, a reduction in pneumococcal resistance as a result of pneumococcal vaccination was observed. Molecular surveillance of colonization in Dutch children shows no effect of pneumococcal conjugate vaccination on the degree of genetic clustering and the genetic structure of the pneumococcal population. However, within the genetic pneumococcal population structure, a clear shift toward nonvaccine serotype clusters was observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634953      PMCID: PMC540185          DOI: 10.1128/JCM.43.1.74-83.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

Authors:  B G Spratt; B M Greenwood
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

2.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.

Authors:  Ron Dagan; Noga Givon-Lavi; Orly Zamir; Merav Sikuler-Cohen; Lior Guy; Jacob Janco; Pablo Yagupsky; Drora Fraser
Journal:  J Infect Dis       Date:  2002-03-04       Impact factor: 5.226

3.  Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.

Authors:  Althea W McCormick; Cynthia G Whitney; Monica M Farley; Ruth Lynfield; Lee H Harrison; Nancy M Bennett; William Schaffner; Arthur Reingold; James Hadler; Paul Cieslak; Matthew H Samore; Marc Lipsitch
Journal:  Nat Med       Date:  2003-03-10       Impact factor: 53.440

4.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

5.  Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study.

Authors:  D Bogaert; M N Engelen; A J Timmers-Reker; K P Elzenaar; P G Peerbooms; R A Coutinho; R de Groot; P W Hermans
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999.

Authors:  A J de Neeling; B P Overbeek; A M Horrevorts; E E Ligtvoet; W G Goettsch
Journal:  J Antimicrob Chemother       Date:  2001-09       Impact factor: 5.790

7.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 8.  Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tract.

Authors:  F Soriano; V Rodriguez-Cerrato
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

9.  Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  Emma Meats; Angela B Brueggemann; Mark C Enright; Karen Sleeman; David T Griffiths; Derrick W Crook; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer.

Authors:  Johanna Jefferies; Stuart C Clarke; Mathew A Diggle; Andrew Smith; Chris Dowson; Tim Mitchell
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

View more
  5 in total

1.  Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A.

Authors:  Mamie T Coats; Trudy Murphy; James C Paton; Barry Gray; David E Briles
Journal:  Microb Pathog       Date:  2011-03-04       Impact factor: 3.738

2.  Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.

Authors:  David T Glover; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2008-04-07       Impact factor: 3.441

Review 3.  Immunologic screening of children with recurrent otitis media.

Authors:  Selma P Wiertsema; Reinier H Veenhoven; Elisabeth A M Sanders; Ger T Rijkers
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

4.  Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.

Authors:  Laura Temime; Pierre-Yves Boelle; Lulla Opatowski; Didier Guillemot
Journal:  PLoS One       Date:  2008-09-19       Impact factor: 3.240

5.  The post-vaccine microevolution of invasive Streptococcus pneumoniae.

Authors:  Amelieke J H Cremers; Fredrick M Mobegi; Marien I de Jonge; Sacha A F T van Hijum; Jacques F Meis; Peter W M Hermans; Gerben Ferwerda; Stephen D Bentley; Aldert L Zomer
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.